Skip to content

Menu

Home About Services Contact
Keller and Heckman LLP logo

The Continuum of Risk

A Law Blog for Vapor, Tobacco and Reduced-Harm Product Companies

hemp

Subscribe to hemp
GW PHARM

Supplemental New Drug Application Submitted for FDA-Approved CBD Drug Epidiolex

By Azim Chowdhury & Neelam Gill on February 11, 2020
Posted in CBD, FDA
Photo of Azim Chowdhury

Reposted from Keller and Heckman’s Blog, The Daily Intake

  • As previously reported in this blog, the 2018 Farm Bill removed hemp – defined as Cannabis sativa L. with less than 0.3% THC on a dry weight basis – from the definition of “marijuana.” As a result, while marijuana remains a Schedule I

…

FDA Announces New Steps to Advance Regulatory Framework for CBD Products

By Keller and Heckman on April 3, 2019
Posted in CBD
CBD

Reposted from Keller and Heckman’s Blog, The Daily Intake

  • Interest in products derived from cannabis (Cannabis sativa L.) and its components, including cannabidiol (CBD) has been high for the past couple of years and only increased when Congress passed the 2018 Farm Bill in December 2018.  Among other things, the law established a category for 

…

Stay Connected

LinkedIn RSS Twitter

Blog Authors Show/Hide

  • Azim Chowdhury
  • Keller and Heckman
  • Eric Gotting
  • Sheila Millar
  • Boaz I. Green
  • LieAnn Van-Tull
  • JC Walker
  • John Gustafson
  • Kathryn C. Skaggs
  • Natalie Rainer
  • Tracy Marshall
  • Manesh Rath
  • Mitzi Ng Clark
  • Arthur S. Garrett III
  • Neelam Gill
  • Paula Pastuskovas
  • Eric Gu
  • David Ettinger
  • Robert Niemann

Topics

Archives

Recent Updates

  • Agenda and Speakers Announced: 2021 E-Vapor and Tobacco Law Symposium
  • E-Vapor and Tobacco Law Symposium – Registration Is Now Open
  • FDA Releases Updated Module, “Tobacco Registration and Listing Module Next Generation (TRLM NG)” for Tobacco Product Manufacturing Establishments
  • A New Policy by HHS Secretary Alex Azar Will Prevent FDA and Other Health Agencies From Signing Final Rules
  • Keller and Heckman LLP Files Citizen Petition Requesting 180-day Extension of PMTA Deadline for Small Open-System Vape Companies Due to COVID-19

The Continuum of Risk

Keller and Heckman LLP
Washington, D.C. / San Francisco Brussels / Shanghai / Paris
LinkedIn RSS Twitter
DisclaimerUpdated Privacy and Cookies Policy

About our Firm

Keller and Heckman, founded in 1962, has a broad practice in the areas of regulatory law, litigation, and business transactions, serving both domestic and international clients. Our firm is a pioneer in the use of interdisciplinary approaches to problem-solving. Since 1971, we have had an in-house scientific staff that works closely with the firm’s attorneys on matters of technical complexity. Many of our attorneys also have government experience and expertise in multiple areas of the law.

Read More…
Copyright © 2021, Keller and Heckman LLP. All Rights Reserved.
Powered By LexBlog

We and our analytics and advertising providers may use cookies and similar technologies to enhance the browsing experience, facilitate sharing of content, and generate statistics about use of the website. For more information or to change your preferences, click here.

I Agree